Letter: All stem cell procedures are not the sameKelowna Capital NewsRecently a doctor from Washington took out several full-page newspaper ads throughout the Okanagan. He sent his marketing people up here to do about 20, ninety-minute seminars about s… Continue reading
Letter: All stem cell procedures are not the sameKelowna Capital NewsRecently a doctor from Washington took out several full-page newspaper ads throughout the Okanagan. He sent his marketing people up here to do about 20, ninety-minute seminars about s… Continue reading
Business in VancouverTechnology Impact Awards: Stemcell Technologies named company of the yearBusiness in VancouverOriginally launched as a small University of B.C. spinoff in 1993, the company of the year winner, Stemcell Technologies Inc., now employ… Continue reading
Endpoints News |
Celgene-backed CRISPR company emerges with $68M Series A
BioPharma Dive After an 18-month stealth period, Repare Therapeutics has burst into the limelight with a $68 million Series A funding, a CRISPR-enabled synthetic lethality drug discovery platform and a pipeline of three preclinical programs targeting “vulnerabilities … CRISPR crew’s lab test spotlights lead program in sickle cell disease, beta-thalassemiaEndpoints News Analyst Recommendations And Earnings Forecast: CRISPR Therapeutics AG (CRSP), JD.com, Inc. (JD)Post Analyst Crispr Theraptc (CRSP) Given $26.75 Consensus Target Price by BrokeragesBNB Daily (blog) Stock Observer –BBNS all 11 news articles » |
STAT |
Early Data for bluebird bio Gene–Therapy Candidate Show Some Promise
Genetic Engineering & Biotechnology News bluebird bio today disclosed its first data, including some promising results, from a pair of clinical studies assessing its LentiGlobin™ gene therapy candidate—including a Phase III study that followed a change in its manufacturing process. In the … Bluebird Bio’s gene therapy for blood disorders yields some impressive results ― but also raises questionsSTAT Bluebird Reports Early Results From Upgraded Gene TherapyXconomy Bluebird bio steps up with a promising snapshot of its gene therapy upgradeEndpoints News FierceBiotech –Business Wire (press release) –StreetInsider.com all 10 news articles » |
Medscape |
Immunotherapy: New Era for NSCLC Management
Medscape It is not often that “a new standard of care” or “remarkable” are bandied about to describe study results for novel compounds, but this is exactly what happened when trial data on immunotherapies for lung cancer were released last fall. |
Medscape |
Immunotherapy: New Era for NSCLC Management
Medscape It is not often that “a new standard of care” or “remarkable” are bandied about to describe study results for novel compounds, but this is exactly what happened when trial data on immunotherapies for lung cancer were released last fall. |
|
Focused Ultrasound Foundation, Cancer Research Institute partner to advance immunotherapy research
Healio Our goal at Cancer Research Institute is to accelerate the field of cancer immunotherapy, and we believe that focused ultrasound is a valuable tool that could increase efficacy.” Through the partnership, the organizations will establish a joint fund to … |